Novo Nordisk Balance Sheet Health
Financial Health criteria checks 4/6
Novo Nordisk has a total shareholder equity of DKK106.6B and total debt of DKK21.3B, which brings its debt-to-equity ratio to 20%. Its total assets and total liabilities are DKK314.5B and DKK207.9B respectively. Novo Nordisk's EBIT is DKK104.0B making its interest coverage ratio -197.3. It has cash and short-term investments of DKK30.2B.
Key information
20.0%
Debt to equity ratio
kr.21.28b
Debt
Interest coverage ratio | -197.3x |
Cash | kr.30.23b |
Equity | kr.106.56b |
Total liabilities | kr.207.93b |
Total assets | kr.314.49b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: NOVOB N's short term assets (DKK139.6B) do not cover its short term liabilities (DKK169.7B).
Long Term Liabilities: NOVOB N's short term assets (DKK139.6B) exceed its long term liabilities (DKK38.3B).
Debt to Equity History and Analysis
Debt Level: NOVOB N has more cash than its total debt.
Reducing Debt: NOVOB N's debt to equity ratio has increased from 1% to 20% over the past 5 years.
Debt Coverage: NOVOB N's debt is well covered by operating cash flow (511.8%).
Interest Coverage: NOVOB N earns more interest than it pays, so coverage of interest payments is not a concern.